Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
12.40
+0.24 (1.97%)
Apr 13, 2026, 1:19 PM EDT - Market open
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $764.74 million as of April 13, 2026. Its market cap has increased by 224.64% in one year.
Market Cap
764.74M
Enterprise Value
531.62M
1-Year Change
224.64%
Ranking
Category
Stock Price
$12.40
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $764.74M, a decrease of -65.33%. That is a compound annual growth rate of -18.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 749.93M | 40.35% |
| Dec 31, 2025 | 534.32M | 52.95% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ARS Pharmaceuticals | 799.34M |
| MannKind | 793.61M |
| Maravai LifeSciences Holdings | 789.20M |
| Solid Biosciences | 789.10M |
| Kura Oncology | 765.82M |
| Relmada Therapeutics | 764.64M |
| MeiraGTx Holdings | 730.57M |
| Lexicon Pharmaceuticals | 728.73M |